To address these unresolved questions, we herein provide the first evidence to prove that, in a panel of human colorectal cancer cell lines, obatoclax inhibits cell proliferation and provokes G1-phase arrest as a result of cyclin D1 downregulation through accelerating proteasome-mediated cyclin D1 degradation. This evidence concerns the gene CCND1 and colorectal cancer.